IRADIMED CORPORATION

NasdaqCM:IRMD Stock Report

Market Cap: US$549.2m

IRADIMED Past Earnings Performance

Past criteria checks 5/6

IRADIMED has been growing earnings at an average annual rate of 22.1%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 15% per year. IRADIMED's return on equity is 24.1%, and it has net margins of 26.2%.

Key information

22.1%

Earnings growth rate

18.5%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate15.0%
Return on equity24.1%
Net Margin26.2%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

If EPS Growth Is Important To You, IRadimed (NASDAQ:IRMD) Presents An Opportunity

Feb 23
If EPS Growth Is Important To You, IRadimed (NASDAQ:IRMD) Presents An Opportunity

Getting In Cheap On IRadimed Corporation (NASDAQ:IRMD) Is Unlikely

Feb 07
Getting In Cheap On IRadimed Corporation (NASDAQ:IRMD) Is Unlikely

Should You Investigate IRadimed Corporation (NASDAQ:IRMD) At US$45.06?

Nov 06
Should You Investigate IRadimed Corporation (NASDAQ:IRMD) At US$45.06?

Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)

Oct 13
Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD)

At US$41.26, Is It Time To Put IRadimed Corporation (NASDAQ:IRMD) On Your Watch List?

Feb 05
At US$41.26, Is It Time To Put IRadimed Corporation (NASDAQ:IRMD) On Your Watch List?

Iradimed withdraws FDA filing for new infusion pump; prelim Q3 revenue rises 13% Y/Y

Oct 10

IRadimed: Record Revenue Could Translate To Share Price Appreciation

Aug 23

Here's Why We Think IRadimed (NASDAQ:IRMD) Is Well Worth Watching

Aug 17
Here's Why We Think IRadimed (NASDAQ:IRMD) Is Well Worth Watching

iRadimed Non-GAAP EPS of $0.26 beats by $0.02, revenue of $12.7M beats by $0.06M

Jul 29

IRadimed: Reduce Equity Beta With Upside Capture

Jul 18

IRadimed (NASDAQ:IRMD) Might Be Having Difficulty Using Its Capital Effectively

Jul 13
IRadimed (NASDAQ:IRMD) Might Be Having Difficulty Using Its Capital Effectively

At US$48.60, Is IRadimed Corporation (NASDAQ:IRMD) Worth Looking At Closely?

Feb 05
At US$48.60, Is IRadimed Corporation (NASDAQ:IRMD) Worth Looking At Closely?

Here's What's Concerning About IRadimed's (NASDAQ:IRMD) Returns On Capital

Jan 12
Here's What's Concerning About IRadimed's (NASDAQ:IRMD) Returns On Capital

Returns On Capital At IRadimed (NASDAQ:IRMD) Paint A Concerning Picture

Jul 13
Returns On Capital At IRadimed (NASDAQ:IRMD) Paint A Concerning Picture

iRadimed EPS beats by $0.04, beats on revenue

Apr 30

iRadimed EPS misses by $0.02, beats on revenue

Feb 04

If You Had Bought IRadimed (NASDAQ:IRMD) Stock Five Years Ago, You Could Pocket A 70% Gain Today

Jan 31
If You Had Bought IRadimed (NASDAQ:IRMD) Stock Five Years Ago, You Could Pocket A 70% Gain Today

Revenue & Expenses Breakdown
Beta

How IRADIMED makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:IRMD Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 236617273
30 Sep 236316263
30 Jun 236015253
31 Mar 235614253
31 Dec 225313232
30 Sep 225013232
30 Jun 224812222
31 Mar 224510212
31 Dec 21429202
30 Sep 21386172
30 Jun 21355172
31 Mar 21321192
31 Dec 20321202
30 Sep 20344232
30 Jun 20365232
31 Mar 203910201
31 Dec 193910201
30 Sep 19368181
30 Jun 19348171
31 Mar 19327161
31 Dec 18306162
30 Sep 18295151
30 Jun 18273152
31 Mar 18252152
31 Dec 17230152
30 Sep 17221142
30 Jun 17243132
31 Mar 17295142
31 Dec 16327141
30 Sep 16358151
30 Jun 16359142
31 Mar 16338132
31 Dec 15318122
30 Sep 15265112
30 Jun 15224101
31 Mar 1519391
31 Dec 1415281
30 Sep 1415271
30 Jun 1414261
31 Mar 1412251
31 Dec 1311251

Quality Earnings: IRMD has a high level of non-cash earnings.

Growing Profit Margin: IRMD's current net profit margins (26.2%) are higher than last year (24.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: IRMD's earnings have grown significantly by 22.1% per year over the past 5 years.

Accelerating Growth: IRMD's earnings growth over the past year (34%) exceeds its 5-year average (22.1% per year).

Earnings vs Industry: IRMD earnings growth over the past year (34%) exceeded the Medical Equipment industry 8.7%.


Return on Equity

High ROE: IRMD's Return on Equity (24.1%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.